We are enrolling volunteers aged 55 or over who struggle with falling or staying asleep as well as waking up at night to urinate for our latest insomnia and nocturia research study.

The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare has multiple options available to participate in migraine trials. 

The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare is enrolling a research study evaluating an investigational preventive treatment of migraine in children and teens ages 6 – 17. 

Accellacare offers research participation options for those with MS such as; advancing current treatments, finding new therapies, and addressing associated symptoms.

Accellacare is enrolling a research study evaluating an investigational medication for Parkinson's disease. Eligible participants will receive study-related care and study medication at no cost.

The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare has multiple options available to participate in migraine trials.

The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare is enrolling a research study evaluating an investigational preventive treatment of migraine in children and teens ages 6 – 17. 

This one-visit research study is evaluating blood samples collected from those with various types of thyroid/autoimmune diseases. Results will aid in understanding biomarkers associated with autoimmune thyroid diseases.

This one-visit research study is evaluating blood samples collected from those with various types of thyroid/autoimmune diseases. Results will aid in understanding biomarkers associated with autoimmune thyroid diseases.

Accellacare is enrolling a research study evaluating an investigational medication for agitation associated with Alzheimer's disease. Eligible participants will receive study-related care and study medication at no cost.

This one-visit research study is evaluating blood samples collected from those with various types of thyroid/autoimmune diseases. Results will aid in understanding biomarkers associated with autoimmune thyroid diseases.

Accellacare is enrolling adults who display COVID-19 symptoms, but are not at risk for severe illness. Eligible participants will receive study-related care and medication at no cost. Financial compensation will also be provided for time and travel expenses.

Accellacare is enrolling adults for a vaccine research study. Eligible participants will receive study-related care and study vaccine at no cost. Financial compensation will also be provided for time and travel expenses.

Accellacare is enrolling a research study for current e-cigarettes, vape, Juul, e-pen users to evaluate an ENDS. Eligible participants will receive financial compensation of for time and travel and access to ENDS for the duration of the study.

Accellacare provides options for health adults over 18 to be a part of medical advancements. Eligible participants will receive study-related care and financial compensation for time and travel.